Seroxat

Basic Seroxat information

• INN (international nonproprietary name): Paroxetine
• Brand names available in the United Kingdom: Seroxat (tablets, liquid oral solution)
• ATC code: N06AB05
• Forms & Dosages: tablets 10 mg, 20 mg, 30 mg; oral suspension 10 mg/5 ml
• Manufacturers in the United Kingdom: original manufacturer GSK (GlaxoSmithKline); generics include Apotex, Sandoz, Teva
• Registration status in the United Kingdom: Prescription-only medicine (Rx) for branded Seroxat and generics
• OTC / Rx classification: Prescription only (Rx) in the United Kingdom

Legal status and availability in the UK

In our online pharmacy, Seroxat is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Clinical effectiveness in the UK

People commonly want to know how quickly Seroxat works and how it performs in real NHS practice.

Seroxat remains an evidence‑based option for major depressive disorder, panic disorder, obsessive‑compulsive disorder and several anxiety conditions within NHS pathways.

Therapeutic benefit for mood and anxiety symptoms typically appears after two to four weeks, with maintenance treatment often required for six to twelve months to prevent relapse.

Early discontinuation may be more frequent than with sertraline or escitalopram, often driven by nausea, sedation or sexual side effects.

For obsessive‑compulsive disorder and other high‑dose indications, efficacy is maintained at higher doses, starting at 20 mg and titrating to 40–60 mg/day as needed.

Combined care models that include psychological therapy (for example through IAPT access in the NHS) improve remission rates compared with medication alone.

• Common outcome measures: PHQ‑9, GAD‑7, Y‑BOCS

Indications and expanded uses

Patients often ask what conditions Seroxat is licensed to treat in the UK.

UK licensed indications for Seroxat include major depressive disorder, panic disorder, generalised anxiety disorder, social anxiety disorder, obsessive‑compulsive disorder and PTSD.

Off‑label uses, for example in certain chronic pain syndromes or menopausal vasomotor symptoms, are occasionally considered by specialists.

Composition and brand landscape

People asking about what is in Seroxat want clear, simple facts.

The active ingredient is paroxetine (INN), an SSRI with ATC code N06AB05.

In the United Kingdom Seroxat is the branded product and is available as tablets and a liquid oral solution.

Tablets are supplied in 10 mg, 20 mg and 30 mg strengths, and an oral suspension is available as 10 mg/5 ml.

GSK (GlaxoSmithKline) is the original manufacturer of Seroxat, and generic paroxetine is supplied by manufacturers such as Apotex, Sandoz and Teva.

Contraindications and special precautions

One of the first questions is whether Seroxat will interact with existing medicines or conditions.

Absolute contraindications include recent or concurrent MAOI use (allow 14 days), concomitant pimozide or thioridazine and any known hypersensitivity to paroxetine or excipients.

Relative cautions include epilepsy or seizure history, bipolar disorder (risk of manic switch), bleeding disorders and hyponatraemia risk in older adults or those on diuretics.

Exercise caution and monitoring in significant hepatic or renal impairment and discuss pregnancy and breastfeeding thoroughly due to reported signals with first‑trimester exposure.

• Checklist for monitoring: review concomitant medicines; check sodium in elderly patients; counsel on bleeding risk with NSAIDs/anticoagulants.

Dosage guidelines (NHS‑oriented)

Patients frequently ask, "What dose should I start on and how fast can I increase or stop Seroxat?"

For most adults start at 20 mg once daily for MDD, GAD and social anxiety disorder.

For panic disorder begin at 10 mg and titrate up as tolerated to usual ranges; for OCD titration to 40–60 mg/day may be necessary.

Elderly patients typically start at 10 mg with slower titration and lower maximum doses because of hyponatraemia risk and possible accumulation.

In hepatic or renal impairment start low (for example 10 mg/day) and titrate cautiously, with some trusts capping maximum doses at around 40 mg/day for safety.

Treatment duration is commonly a minimum of six to twelve months for depression, with longer courses for recurrent illness or severe anxiety disorders.

Tapering on discontinuation should be gradual over weeks or months to reduce withdrawal symptoms.

• Missed dose: take the same day if remembered; do not double up.
• Overdose: supportive care; watch for nausea, tremor, sedation, tachycardia or seizures and seek emergency help.

Interactions overview

Many patients want to know which medicines to avoid while taking Seroxat.

Do not combine paroxetine with monoamine oxidase inhibitors or with pimozide or thioridazine because of severe interactions including serotonin syndrome and QT prolongation.

Concomitant use with other serotonergic agents (triptans, SNRIs, some opioids) increases serotonin syndrome risk and should be managed carefully.

Paroxetine is a moderate to strong CYP2D6 inhibitor and can reduce activation of tamoxifen, affect certain antipsychotics and alter beta‑blocker metabolism.

Co‑prescribing with NSAIDs or anticoagulants raises bleeding risk; monitor and counsel patients accordingly.

Comparable medicines and prescribing preferences

Patients often ask whether Seroxat is better or worse than other SSRIs.

Sertraline and citalopram/escitalopram are commonly recommended first‑line within many NHS pathways, with paroxetine selected when prior response or specific indications favour it.

Alternatives include SNRIs such as venlafaxine and duloxetine, and atypicals such as mirtazapine or bupropion for particular clinical profiles.

• Pros for paroxetine: established efficacy across anxiety disorders and OCD; useful at higher doses for OCD and severe panic.
• Cons for paroxetine: higher anticholinergic effects, weight gain potential, sexual dysfunction and stronger CYP2D6 inhibition than some alternatives.

Prescribers weigh side‑effect profile, drug interactions (for example with tamoxifen), pregnancy plans and comorbidities when choosing between paroxetine, sertraline and fluoxetine.

Frequently asked questions

Q: How long until Seroxat works?

A: Expect initial benefits in two to four weeks, with six to twelve months treatment commonly recommended for depression.

Q: Can I stop quickly if I feel better?

A: No; gradual tapering is advised to minimise withdrawal symptoms.

Q: Is paroxetine safe in pregnancy?

A: Discuss risks with your GP or specialist; some studies report signals with first‑trimester exposure and alternatives may be considered.

Q: Will paroxetine make me sleepy or affect driving?

A: Drowsiness or dizziness may occur; avoid driving until you know how the medicine affects you.

For further reading and official advice, consult NHS guidance, MHRA materials and local IAPT services.

Guidelines for proper use and pharmacist counselling

When counselling patients, focus on indication, dosing, expected onset and common side effects.

Explain starting doses clearly: 20 mg/day for most adults and 10 mg for elderly patients or panic disorder starts.

Discuss interactions with MAOIs, pimozide, anticoagulants and tamoxifen, and reinforce the need to report adverse events via the MHRA Yellow Card scheme.

Use teach‑back to confirm understanding about missed doses and advise on alcohol avoidance and driving precautions until tolerance is established.

Signpost to GP review timelines, IAPT for psychological treatment options and emergency mental‑health contacts where appropriate.

• Pharmacist counselling checklist: indication, dose, onset, side effects, interactions, pregnancy advice, tapering plan and Yellow Card reporting instructions.

Delivery across the United Kingdom